Latest return on equity
Intellia Therapeutics Return on equity
Direct answer
Intellia Therapeutics's return on equity is -55.44%.
The verified market snapshot reports -55.44%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Intellia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -55.44%
Explore related company data
View Intellia Therapeutics's market capitalizationView Intellia Therapeutics's price-to-book ratioView Intellia Therapeutics's dividend yieldView Intellia Therapeutics's 52-week price rangeView Intellia Therapeutics's revenue growthView Intellia Therapeutics's profit marginView Intellia Therapeutics's debt-to-equity ratioView all Intellia Therapeutics key metricsReturn to Intellia Therapeutics profile